Roundtable: Endurance Unveiled: TCR Therapies Showcasing Durability in Solid Tumors
Time: 3:15 pm
day: Conference Day One
Details:
• Discuss key clinical trials highlighting the enduring efficacy of TCR therapies in solid tumors, emphasizing long-term patient responses and sustained anti-tumor effects
• Explore the underlying mechanisms contributing to the durability of TCR therapies in solid tumors, delving into factors influencing persistence and resistance patterns
• Engage patients and experts to discuss lived experiences and future expectations regarding the long-lasting benefits of TCR therapies in managing solid tumors
